Jane Street Group, LLC Biotech Acquisition CO Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$9.92 - $10.11 $22,528 - $22,959	-2,271 Reduced 1.56%	143,071 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$9.83 - $9.92 $1.52 Million - $1.53 Million	-154,578 Reduced 51.54%	145,342 $1.44 Million
Q2 2022 Aug 16, 2022	BUY	$8.96 - $9.97 $1.48 Million - $1.65 Million	165,509 Added 123.14%	299,920 $2.97 Million
Q3 2021 Nov 16, 2021	BUY	$9.64 - $9.75 $22,287 - $22,542	2,312 Added 1.75%	134,411 $1.31 Million
Q2 2021 Aug 16, 2021	BUY	$9.64 - $9.88 $254,418 - $260,752	26,392 Added 24.97%	132,099 $1.28 Million
Q1 2021 May 18, 2021	BUY	$9.56 - $9.73 $1.01 Million - $1.03 Million	105,707 New	105,707 $1.03 Million

Others Institutions Holding BIOT

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Biotech Acquisition Co

Ticker BIOT
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 23,000,000
Description
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

More about BIOT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.